This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
25, 2021 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of AIT France (“AIT”), a manufacturer and distributor of innovative consumables for analyticalchemistry and chromatography. Headquartered in Paris, France, AIT supplies public and private researchers and pharmaceutical laboratories.
I started working as a trainee immediately after submitting my PhD thesis in Analyticalchemistry to Pune university in India but initially felt immense pressure to prove myself, not only because I was a woman but also because there were very few PhD staff, in general. I am currently leading USP’s Nitrosamine workstream, globally.
Horizon Therapeutics – Karin Rosén joined Ireland-based Horizon Therapeutics as executive vice president, research and development and chief scientific officer. X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Venugopal most recently served as executive director at Intercept Pharmaceuticals.
Joel Cresser-Brown: I enjoyed lab work, I fortunately work in a team containing 2 product managers and 4 research scientists so it’s very scientifically focused. I have a year long masters project based within a CRO’s analyticalchemistry innovations department initially working in the lab.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content